Issue Date: January 2, 2012
Ipsen Will Build center in Massachusetts
The French drug company Ipsen will invest $45 million to expand its R&D center in Milford, Mass. The site’s current staff of 150 includes chemists, biologists, and translational science experts working on the firm’s peptide and toxin R&D platforms. A new building, set to open in 2014, will house R&D and process science centers that support Ipsen’s goal of delivering five new molecular entities and three drug proofs of concept by 2015.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society